E. Clay

758 total citations
61 papers, 522 citations indexed

About

E. Clay is a scholar working on Economics and Econometrics, Epidemiology and Social Psychology. According to data from OpenAlex, E. Clay has authored 61 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Economics and Econometrics, 10 papers in Epidemiology and 8 papers in Social Psychology. Recurrent topics in E. Clay's work include Health Systems, Economic Evaluations, Quality of Life (18 papers), Mental Health Treatment and Access (8 papers) and Genetic Neurodegenerative Diseases (7 papers). E. Clay is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (18 papers), Mental Health Treatment and Access (8 papers) and Genetic Neurodegenerative Diseases (7 papers). E. Clay collaborates with scholars based in France, United States and United Kingdom. E. Clay's co-authors include Mondher Toumi, A. Millier, Pierre Lévy, Nicholas Moore, Bruno Falissard, Samuel Aballéa, Nathalie Largeron, Hélène Bricout, M. Uhart and C. Chouaïd and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

E. Clay

57 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Clay France 13 112 82 70 66 59 61 522
Helen Lee United States 17 47 0.4× 60 0.7× 40 0.6× 46 0.7× 77 1.3× 42 854
Glenn K. Goodrich United States 17 45 0.4× 83 1.0× 21 0.3× 44 0.7× 41 0.7× 44 851
Kelly Bell United States 15 96 0.9× 46 0.6× 33 0.5× 40 0.6× 30 0.5× 36 741
Przemysław Biliński Poland 16 104 0.9× 71 0.9× 49 0.7× 14 0.2× 22 0.4× 44 842
Amy K. O’Sullivan United States 15 185 1.7× 134 1.6× 125 1.8× 118 1.8× 215 3.6× 45 880
Jörg Bätzing Germany 13 87 0.8× 20 0.2× 19 0.3× 29 0.4× 98 1.7× 31 545
Ann Bangerter United States 16 261 2.3× 43 0.5× 249 3.6× 40 0.6× 31 0.5× 41 883
Laura M. Campbell United States 17 56 0.5× 25 0.3× 59 0.8× 31 0.5× 145 2.5× 58 748
Homa Keshavarz Canada 13 36 0.3× 30 0.4× 155 2.2× 96 1.5× 64 1.1× 25 551
Tianyan Hu United States 13 182 1.6× 108 1.3× 10 0.1× 25 0.4× 62 1.1× 46 501

Countries citing papers authored by E. Clay

Since Specialization
Citations

This map shows the geographic impact of E. Clay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Clay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Clay more than expected).

Fields of papers citing papers by E. Clay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Clay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Clay. The network helps show where E. Clay may publish in the future.

Co-authorship network of co-authors of E. Clay

This figure shows the co-authorship network connecting the top 25 collaborators of E. Clay. A scholar is included among the top collaborators of E. Clay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Clay. E. Clay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dziedzic, Jakub, et al.. (2024). Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease. SHILAP Revista de lepidopterología. 12(2). 35–57.
2.
François, C., et al.. (2023). Rapid literature review: definition and methodology. SHILAP Revista de lepidopterología. 11(1). 2241234–2241234. 48 indexed citations
3.
4.
Bowrin, Kevin, J Brière, Laurent Fauchier, et al.. (2020). Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France. PLoS ONE. 15(1). e0225301–e0225301. 10 indexed citations
5.
Chang, Bernard, et al.. (2018). Budget impact model of Mydrane®, a new intracameral injectable used for intra-operative mydriasis, from a UK hospital perspective. BMC Ophthalmology. 18(1). 104–104. 13 indexed citations
6.
7.
Chouaïd, C., Delphine Loirat, E. Clay, et al.. (2017). P1.06-044 Costs of Adverse Events (AE) Associated with Cancer Therapies in Non-Small Cell Lung Cancer (NSCLC) in France. Journal of Thoracic Oncology. 12(1). S693–S693. 1 indexed citations
8.
9.
Chouaïd, C., et al.. (2016). Costs of Adverse Events Associated with Cancer Therapies in Non-Small Cell Lung Cancer in France. Value in Health. 19(7). A743–A743. 2 indexed citations
10.
Yan, Jing, et al.. (2014). Burden of Illness of Dementia in China. Value in Health. 17(7). A767–A767. 1 indexed citations
11.
Belhadj, A., et al.. (2014). Assessment Of The Huntington Clinical Self-Reported Instrument (H-CSRI) Cross-Cultural Validity. Value in Health. 17(7). A567–A567. 1 indexed citations
12.
Clay, E., et al.. (2014). Current Impact of Dementia on the Caregiver in China. Value in Health. 17(7). A722–A722. 1 indexed citations
13.
14.
Clay, E., et al.. (2014). The Growing Challenge Of Managing Age-Related Diseases In China: Example Of Alzheimer’s Disease. Value in Health. 17(3). A65–A65. 1 indexed citations
15.
Clay, E., et al.. (2014). Medicaid population budget impact analysis of buprenorphine/naloxone film and tablet formulation. Value in Health. 17(3). A212–A212. 1 indexed citations
16.
Guelfucci, Florent, E. Clay, Samuel Aballéa, et al.. (2013). Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France. BMC Endocrine Disorders. 13(1). 15–15. 7 indexed citations
17.
18.
Millier, A., et al.. (2012). PMH45 Health-Related Quality of Life Patient-Reported Outcomes in Schizophrenia. Value in Health. 15(7). A342–A342. 1 indexed citations
19.
Dorey, J, Joakim Tedroff, Ferdinando Squitieri, et al.. (2011). PND38 International Comparison of Huntington Disease (HD) Burden. Value in Health. 14(7). A324–A324. 2 indexed citations
20.
Clay, E.. (1981). Food policy issues in low–income Countries. World Bank eBooks. 1. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Lee Breakdown of academic impact, for papers by Glenn K. Goodrich Breakdown of academic impact, for papers by Kelly Bell Breakdown of academic impact, for papers by Przemysław Biliński Breakdown of academic impact, for papers by Amy K. O’Sullivan Breakdown of academic impact, for papers by Jörg Bätzing Breakdown of academic impact, for papers by Ann Bangerter Breakdown of academic impact, for papers by Laura M. Campbell Breakdown of academic impact, for papers by Homa Keshavarz Breakdown of academic impact, for papers by Tianyan Hu
Rankless by CCL
2026